Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06431620
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-05-22
Brief Title:
Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally AdvancedMetastatic Differentiated Thyroid Cancer
Sponsor:
Nanjing First Hospital Nanjing Medical University
Organization:
Nanjing First Hospital Nanjing Medical University
Organization Data
Organization:
Nanjing First Hospital Nanjing Medical University
Class:
OTHER
Study ID:
KY20240514-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanjing First Hospital Nanjing Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Feng Wang
Responsible Party Title:
Director of nuclear medicine department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Nanjing First Hospital Nanjing Medical University
Old Name:
None
Old Organization:
None